ID   HAT1_HUMAN              Reviewed;         419 AA.
AC   O14929; Q49A44; Q53QF0; Q53SU4; Q6P594; Q8WWB9;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   10-MAY-2017, entry version 152.
DE   RecName: Full=Histone acetyltransferase type B catalytic subunit;
DE            EC=2.3.1.48 {ECO:0000269|PubMed:11585814, ECO:0000269|PubMed:22615379, ECO:0000269|PubMed:9427644};
DE   AltName: Full=Histone acetyltransferase 1;
GN   Name=HAT1; Synonyms=KAT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), FUNCTION, ENZYME ACTIVITY,
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RC   TISSUE=Teratocarcinoma;
RX   PubMed=9427644; DOI=10.1016/S0960-9822(98)70040-5;
RA   Verreault A., Kaufman P.D., Kobayashi R., Stillman B.;
RT   "Nucleosomal DNA regulates the core-histone-binding subunit of the
RT   human Hat1 acetyltransferase.";
RL   Curr. Biol. 8:96-108(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 2-419 (ISOFORM A).
RC   TISSUE=Brain, Lung, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=11585814; DOI=10.1074/jbc.C100549200;
RA   Makowski A.M., Dutnall R.N., Annunziato A.T.;
RT   "Effects of acetylation of histone H4 at lysines 8 and 16 on activity
RT   of the Hat1 histone acetyltransferase.";
RL   J. Biol. Chem. 276:43499-43502(2001).
RN   [6]
RP   INDUCTION BY ESTROGEN.
RX   PubMed=12841681;
RA   Sorbello V., Fuso L., Sfiligoi C., Scafoglio C., Ponzone R.,
RA   Biglia N., Weisz A., Sismondi P., De Bortoli M.;
RT   "Quantitative real-time RT-PCR analysis of eight novel estrogen-
RT   regulated genes in breast cancer.";
RL   Int. J. Biol. Markers 18:123-129(2003).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=20148353; DOI=10.1007/s11010-010-0390-0;
RA   Lebel E.A., Boukamp P., Tafrov S.T.;
RT   "Irradiation with heavy-ion particles changes the cellular
RT   distribution of human histone acetyltransferase HAT1.";
RL   Mol. Cell. Biochem. 339:271-284(2010).
RN   [9]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=20953179; DOI=10.1038/nsmb.1911;
RA   Campos E.I., Fillingham J., Li G., Zheng H., Voigt P., Kuo W.H.,
RA   Seepany H., Gao Z., Day L.A., Greenblatt J.F., Reinberg D.;
RT   "The program for processing newly synthesized histones H3.1 and H4.";
RL   Nat. Struct. Mol. Biol. 17:1343-1351(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-343, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 20-341 IN COMPLEX WITH
RP   ACETYL-COA AND HISTONE H4 PEPTIDE, CATALYTIC ACTIVITY, FUNCTION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF ASP-62; GLU-64; GLU-187;
RP   TRP-199; GLU-276 AND ASP-277, ACTIVE SITE, AND INTERACTION WITH
RP   HISTONE H4.
RX   PubMed=22615379; DOI=10.1073/pnas.1114117109;
RA   Wu H., Moshkina N., Min J., Zeng H., Joshua J., Zhou M.M.,
RA   Plotnikov A.N.;
RT   "Structural basis for substrate specificity and catalysis of human
RT   histone acetyltransferase 1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:8925-8930(2012).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] PRO-317.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Acetylates soluble but not nucleosomal histone H4 at
CC       'Lys-5' (H4K5ac) and 'Lys-12' (H4K12ac) and, to a lesser extent,
CC       acetylates histone H2A at 'Lys-5' (H2AK5ac). Has intrinsic
CC       substrate specificity that modifies lysine in recognition sequence
CC       GXGKXG. May be involved in nucleosome assembly during DNA
CC       replication and repair as part of the histone H3.1 and H3.3
CC       complexes. May play a role in DNA repair in response to free
CC       radical damage. {ECO:0000269|PubMed:11585814,
CC       ECO:0000269|PubMed:20953179, ECO:0000269|PubMed:22615379,
CC       ECO:0000269|PubMed:9427644}.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + [protein]-L-lysine = CoA +
CC       [protein]-N(6)-acetyl-L-lysine. {ECO:0000269|PubMed:11585814,
CC       ECO:0000269|PubMed:22615379, ECO:0000269|PubMed:9427644}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=6.68 uM for acetyl-CoA {ECO:0000269|PubMed:22615379};
CC         Note=kcat is 4.14 (sec-1) for acetyl-CoA.
CC         {ECO:0000269|PubMed:22615379};
CC   -!- SUBUNIT: Catalytic subunit of the type B histone acetyltransferase
CC       (HAT) complex, composed of RBBP7 and HAT1. Interacts with histones
CC       H4 and H2A. The interaction is dependent of the ability of RBBP7
CC       to bind to the N-terminus of histones. Component of the histone
CC       H3.1 and H3.3 complexes. {ECO:0000269|PubMed:20953179,
CC       ECO:0000269|PubMed:22615379, ECO:0000269|PubMed:9427644}.
CC   -!- INTERACTION:
CC       P62805:HIST2H4B; NbExp=4; IntAct=EBI-2339359, EBI-302023;
CC       A4D127:MEOX2; NbExp=5; IntAct=EBI-2339359, EBI-10172134;
CC       Q09028:RBBP4; NbExp=3; IntAct=EBI-2339359, EBI-620823;
CC       Q04864:REL; NbExp=3; IntAct=EBI-2339359, EBI-307352;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-2339359, EBI-533224;
CC       Q13829:TNFAIP1; NbExp=3; IntAct=EBI-2339359, EBI-2505861;
CC       P12520:vpr (xeno); NbExp=3; IntAct=EBI-2339359, EBI-6164519;
CC   -!- SUBCELLULAR LOCATION: Isoform A: Nucleus matrix.
CC   -!- SUBCELLULAR LOCATION: Isoform B: Cytoplasm. Nucleus. Nucleus
CC       matrix. Nucleus, nucleoplasm. Note=Localization is predominantly
CC       nuclear in normal cells. Treatment with hydrogen peroxide or
CC       ionizing radiation enhances nuclear localization through
CC       redistribution of existing protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=A; Synonyms=a, Nuclear;
CC         IsoId=O14929-1; Sequence=Displayed;
CC       Name=B; Synonyms=b;
CC         IsoId=O14929-2; Sequence=VSP_041129;
CC   -!- DEVELOPMENTAL STAGE: Highly expressed in mitotic cells (at protein
CC       level). {ECO:0000269|PubMed:20148353}.
CC   -!- INDUCTION: Up-regulated by estrogen.
CC       {ECO:0000269|PubMed:12841681}.
CC   -!- SIMILARITY: Belongs to the HAT1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH18682.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Histone acetyltransferase
CC       entry;
CC       URL="https://en.wikipedia.org/wiki/Histone_acetyltransferase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF030424; AAC02425.1; -; mRNA.
DR   EMBL; AC015976; AAY14731.1; -; Genomic_DNA.
DR   EMBL; AC114745; AAX93247.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11195.1; -; Genomic_DNA.
DR   EMBL; BC018682; AAH18682.1; ALT_INIT; mRNA.
DR   EMBL; BC045673; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC063003; AAH63003.1; -; mRNA.
DR   CCDS; CCDS2245.1; -. [O14929-1]
DR   RefSeq; NP_003633.1; NM_003642.3. [O14929-1]
DR   UniGene; Hs.632532; -.
DR   PDB; 2P0W; X-ray; 1.90 A; A/B=20-341.
DR   PDBsum; 2P0W; -.
DR   ProteinModelPortal; O14929; -.
DR   SMR; O14929; -.
DR   BioGrid; 114092; 44.
DR   DIP; DIP-52811N; -.
DR   IntAct; O14929; 29.
DR   MINT; MINT-2795393; -.
DR   STRING; 9606.ENSP00000264108; -.
DR   iPTMnet; O14929; -.
DR   PhosphoSitePlus; O14929; -.
DR   BioMuta; HAT1; -.
DR   EPD; O14929; -.
DR   MaxQB; O14929; -.
DR   PaxDb; O14929; -.
DR   PeptideAtlas; O14929; -.
DR   PRIDE; O14929; -.
DR   DNASU; 8520; -.
DR   Ensembl; ENST00000264108; ENSP00000264108; ENSG00000128708.
DR   GeneID; 8520; -.
DR   KEGG; hsa:8520; -.
DR   UCSC; uc002uhi.4; human. [O14929-1]
DR   CTD; 8520; -.
DR   DisGeNET; 8520; -.
DR   GeneCards; HAT1; -.
DR   HGNC; HGNC:4821; HAT1.
DR   HPA; CAB037191; -.
DR   HPA; HPA036788; -.
DR   MIM; 603053; gene.
DR   neXtProt; NX_O14929; -.
DR   PharmGKB; PA29197; -.
DR   eggNOG; KOG2696; Eukaryota.
DR   eggNOG; ENOG410XPH4; LUCA.
DR   HOGENOM; HOG000231943; -.
DR   HOVERGEN; HBG005945; -.
DR   InParanoid; O14929; -.
DR   KO; K11303; -.
DR   OrthoDB; EOG091G0A79; -.
DR   PhylomeDB; O14929; -.
DR   TreeFam; TF314995; -.
DR   BRENDA; 2.3.1.48; 2681.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   ChiTaRS; HAT1; human.
DR   EvolutionaryTrace; O14929; -.
DR   GeneWiki; HAT1; -.
DR   GenomeRNAi; 8520; -.
DR   PRO; PR:O14929; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000128708; -.
DR   CleanEx; HS_HAT1; -.
DR   ExpressionAtlas; O14929; baseline and differential.
DR   Genevisible; O14929; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:UniProtKB.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; IDA:BHF-UCL.
DR   GO; GO:0016363; C:nuclear matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0043234; C:protein complex; IDA:UniProtKB.
DR   GO; GO:0010485; F:H4 histone acetyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0004402; F:histone acetyltransferase activity; TAS:ProtInc.
DR   GO; GO:0042393; F:histone binding; IBA:GO_Central.
DR   GO; GO:0006348; P:chromatin silencing at telomere; IEA:InterPro.
DR   GO; GO:0006323; P:DNA packaging; TAS:ProtInc.
DR   GO; GO:0006335; P:DNA replication-dependent nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0006336; P:DNA replication-independent nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0043967; P:histone H4 acetylation; IDA:UniProtKB.
DR   GO; GO:0006475; P:internal protein amino acid acetylation; TAS:ProtInc.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   Gene3D; 3.90.360.10; -; 1.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR019467; Hat1_N.
DR   InterPro; IPR017380; Hist_AcTrfase_B-typ_cat-su.
DR   PANTHER; PTHR12046; PTHR12046; 1.
DR   Pfam; PF10394; Hat1_N; 1.
DR   PIRSF; PIRSF038084; HAT-B_cat; 1.
DR   SUPFAM; SSF55729; SSF55729; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Alternative splicing;
KW   Complete proteome; Cytoplasm; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895}.
FT   CHAIN         2    419       Histone acetyltransferase type B
FT                                catalytic subunit.
FT                                /FTId=PRO_0000083902.
FT   REGION       62     64       Interaction with histone H4 N-terminus.
FT                                {ECO:0000269|PubMed:22615379}.
FT   REGION      225    227       Interaction with histone H4 N-terminus.
FT                                {ECO:0000305}.
FT   REGION      241    243       Acetyl-CoA binding.
FT                                {ECO:0000269|PubMed:22615379}.
FT   REGION      248    254       Acetyl-CoA binding.
FT                                {ECO:0000269|PubMed:22615379}.
FT   ACT_SITE    276    276       Proton donor/acceptor.
FT                                {ECO:0000303|PubMed:22615379}.
FT   SITE        199    199       Interaction with histone H4 N-terminus.
FT                                {ECO:0000269|PubMed:22615379}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895}.
FT   MOD_RES       9      9       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BY71}.
FT   MOD_RES      15     15       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BY71}.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     85       Missing (in isoform B).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_041129.
FT   VARIANT     317    317       A -> P (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035997.
FT   MUTAGEN      62     62       D->A: Strongly reduces HAT activity.
FT                                {ECO:0000269|PubMed:22615379}.
FT   MUTAGEN      64     64       E->A: Strongly reduces HAT activity.
FT                                {ECO:0000269|PubMed:22615379}.
FT   MUTAGEN     187    187       E->Q: Strongly reduces HAT activity.
FT                                {ECO:0000269|PubMed:22615379}.
FT   MUTAGEN     199    199       W->A: Strongly reduces HAT activity.
FT                                {ECO:0000269|PubMed:22615379}.
FT   MUTAGEN     276    276       E->Q: Strongly reduces HAT activity.
FT                                {ECO:0000269|PubMed:22615379}.
FT   MUTAGEN     277    277       D->N: Strongly reduces HAT activity.
FT                                {ECO:0000269|PubMed:22615379}.
FT   STRAND       26     28       {ECO:0000244|PDB:2P0W}.
FT   HELIX        29     32       {ECO:0000244|PDB:2P0W}.
FT   STRAND       33     40       {ECO:0000244|PDB:2P0W}.
FT   HELIX        41     44       {ECO:0000244|PDB:2P0W}.
FT   HELIX        47     49       {ECO:0000244|PDB:2P0W}.
FT   HELIX        57     60       {ECO:0000244|PDB:2P0W}.
FT   TURN         61     64       {ECO:0000244|PDB:2P0W}.
FT   STRAND       65     71       {ECO:0000244|PDB:2P0W}.
FT   STRAND       73     79       {ECO:0000244|PDB:2P0W}.
FT   TURN         80     82       {ECO:0000244|PDB:2P0W}.
FT   STRAND       85     90       {ECO:0000244|PDB:2P0W}.
FT   STRAND       92     94       {ECO:0000244|PDB:2P0W}.
FT   TURN         97     99       {ECO:0000244|PDB:2P0W}.
FT   STRAND      100    102       {ECO:0000244|PDB:2P0W}.
FT   HELIX       107    112       {ECO:0000244|PDB:2P0W}.
FT   HELIX       123    131       {ECO:0000244|PDB:2P0W}.
FT   HELIX       132    135       {ECO:0000244|PDB:2P0W}.
FT   STRAND      140    148       {ECO:0000244|PDB:2P0W}.
FT   STRAND      157    164       {ECO:0000244|PDB:2P0W}.
FT   HELIX       171    185       {ECO:0000244|PDB:2P0W}.
FT   STRAND      199    210       {ECO:0000244|PDB:2P0W}.
FT   STRAND      213    229       {ECO:0000244|PDB:2P0W}.
FT   TURN        230    232       {ECO:0000244|PDB:2P0W}.
FT   STRAND      233    243       {ECO:0000244|PDB:2P0W}.
FT   HELIX       245    247       {ECO:0000244|PDB:2P0W}.
FT   HELIX       252    265       {ECO:0000244|PDB:2P0W}.
FT   STRAND      273    277       {ECO:0000244|PDB:2P0W}.
FT   HELIX       280    294       {ECO:0000244|PDB:2P0W}.
FT   HELIX       298    300       {ECO:0000244|PDB:2P0W}.
FT   HELIX       302    305       {ECO:0000244|PDB:2P0W}.
FT   HELIX       311    321       {ECO:0000244|PDB:2P0W}.
FT   HELIX       325    339       {ECO:0000244|PDB:2P0W}.
SQ   SEQUENCE   419 AA;  49513 MW;  509DF06E0E4E2647 CRC64;
     MAGFGAMEKF LVEYKSAVEK KLAEYKCNTN TAIELKLVRF PEDLENDIRT FFPEYTHQLF
     GDDETAFGYK GLKILLYYIA GSLSTMFRVE YASKVDENFD CVEADDVEGK IRQIIPPGFC
     TNTNDFLSLL EKEVDFKPFG TLLHTYSVLS PTGGENFTFQ IYKADMTCRG FREYHERLQT
     FLMWFIETAS FIDVDDERWH YFLVFEKYNK DGATLFATVG YMTVYNYYVY PDKTRPRVSQ
     MLILTPFQGQ GHGAQLLETV HRYYTEFPTV LDITAEDPSK SYVKLRDFVL VKLCQDLPCF
     SREKLMQGFN EDMAIEAQQK FKINKQHARR VYEILRLLVT DMSDAEQYRS YRLDIKRRLI
     SPYKKKQRDL AKMRKCLRPE ELTNQMNQIE ISMQHEQLEE SFQELVEDYR RVIERLAQE
//
